Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management
Cuker, Adam, Bass, Ann D, Nadj, Congor, Agius, Mark A, Steingo, Brian, Selmaj, Krzysztof W, Thoits, Timothy, Guerreiro, Alexandre, Van Wijmeersch, Bart, Ziemssen, Tjalf, Meuth, Sven G, LaGanke, Christopher C, Thangavelu, Karthinathan, Rodriguez, Claudio E, Baker, Darren P, Margolin, David H, Jannsens, Ann
Published in Multiple sclerosis (01.01.2020)
Published in Multiple sclerosis (01.01.2020)
Get full text
Journal Article
Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
Singer, Barry A, Arnold, Douglas L, Drulovic, Jelena, Freedman, Mark S, Gold, Ralf, Gudesblatt, Mark, Jasinska, Elzbieta, LaGanke, Christopher C, Naismith, Robert T, Negroski, Donald, Oh, Jiwon, Hernandez Perez, Miguel Angel, Selmaj, Krzysztof, Then Bergh, Florian, Wundes, Annette, Ziemssen, Tjalf, Castro-Borrero, Wanda, Chen, Hailu, Levin, Seth, Scaramozza, Matthew, Shankar, Sai L, Wang, Ting, Wray, Sibyl
Published in Multiple sclerosis (01.12.2023)
Published in Multiple sclerosis (01.12.2023)
Get full text
Journal Article
Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy
Oh, S J, LaGanke, C, Powers, R, Wolfe, G I, Quinton, R A, Burns, D K
Published in Neurology (22.11.2005)
Published in Neurology (22.11.2005)
Get more information
Journal Article
Effect of Alemtuzumab Infusions on Vital Signs: A Prospective Observational Study in Patients with Relapsing-Remitting Multiple Sclerosis
Chinea, Angel, Honeycutt, William David, Miller, Tamara, Graves, Donna, Jacobs, Alan, Wu, Junlong, LaGanke, Christopher C
Published in International journal of MS care (01.03.2020)
Published in International journal of MS care (01.03.2020)
Get full text
Journal Article
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies
Dayan, Colin M., Lecumberri, Beatriz, Muller, Ilaria, Ganesananthan, Sashiananthan, Hunter, Samuel F., Selmaj, Krzysztof W., Hartung, Hans-Peter, Havrdova, Eva K., LaGanke, Christopher C., Ziemssen, Tjalf, Van Wijmeersch, Bart, Meuth, Sven G., Margolin, David H., Poole, Elizabeth M., Baker, Darren P., Senior, Peter A.
Published in Multiple sclerosis journal - experimental, translational and clinical (01.01.2023)
Published in Multiple sclerosis journal - experimental, translational and clinical (01.01.2023)
Get full text
Journal Article
Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis
LaGanke, Christopher C., Freeman, Deborah W., Whitaker, John N.
Published in Annals of neurology (01.01.2000)
Published in Annals of neurology (01.01.2000)
Get full text
Journal Article
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data
Coles, Alasdair J, Jones, Joanne L, Vermersch, Patrick, Traboulsee, Anthony, Bass, Ann D, Boster, Aaron, Chan, Andrew, Comi, Giancarlo, Fernández, Óscar, Giovannoni, Gavin, Kubala Havrdova, Eva, LaGanke, Christopher, Montalban, Xavier, Oreja-Guevara, Celia, Piehl, Fredrik, Wiendl, Heinz, Ziemssen, Tjalf
Published in Multiple sclerosis (01.04.2022)
Published in Multiple sclerosis (01.04.2022)
Get full text
Journal Article
A cross-reactive anti-myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis
Zhou, S R, Maier, C C, Mitchell, G W, LaGanke, C C, Blalock, J E, Whitaker, J N
Published in Neurology (01.02.1998)
Published in Neurology (01.02.1998)
Get more information
Journal Article
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings
Barclay, Krista, Carruthers, Robert, Traboulsee, Anthony, Bass, Ann D, LaGanke, Christopher, Bertolotto, Antonio, Boster, Aaron, Celius, Elisabeth G, de Seze, Jérôme, Cruz, Dionisio Dela, Habek, Mario, Lee, Jong-Mi, Limmroth, Volker, Meuth, Sven G, Oreja-Guevara, Celia, Pagnotta, Patricia, Vos, Cindy, Ziemssen, Tjalf, Baker, Darren P, Wijmeersch, Bart Van
Published in Frontiers in neurology (22.03.2019)
Published in Frontiers in neurology (22.03.2019)
Get full text
Journal Article
Safety of Alemtuzumab in RRMS Patients in the Period Following Lymphocyte Repopulation: Clinical Trial and Postmarketing Experience
Jones, J, Coml, G, Fernandez, O, Kappos, L, Havrdova, EK, Laganke, C, Greja-Guevara, C, Piehl, F, Traboulsee, A, Vermersch, P, Wiendl, I, Ziemssen, T, Poole, E, Coles, AJ
Published in EUROPEAN JOURNAL OF NEUROLOGY (2020)
Get full text
Published in EUROPEAN JOURNAL OF NEUROLOGY (2020)
Conference Proceeding
Safety of Alemtuzumab Over 9 Years in Patients With Non-MS Autoimmunity
Coles, AJ, Bass, AD, Comi, G, Fernandez, O, Giovannoni, G, Jones, J, Kappos, L, Havrdova, EK, Laganke, C, Montalban, X, Piehl, F, Traboulsee, A, Vermersch, P, Ziemssen, T, Poole, E, Wiendl, H
Published in EUROPEAN JOURNAL OF NEUROLOGY (2020)
Get full text
Published in EUROPEAN JOURNAL OF NEUROLOGY (2020)
Conference Proceeding
Safety of Alemtuzumab in RRMS Patients During the Peri-infusion Period: Clinical Trial and Postmarketing Experience
Vennersch, P, Bass, AD, Boster, A, Chan, A, Coles, AJ, Comic, G, Giovannoni, G, Junes, J, Kappos, L, Laganke, C, Oreja-Guevara, C, Piehl, F, Poole, E, Montalban, X
Published in EUROPEAN JOURNAL OF NEUROLOGY (2020)
Get full text
Published in EUROPEAN JOURNAL OF NEUROLOGY (2020)
Conference Proceeding
Effect of Alemtuzumab Infusions on Vital Signs
Chinea, Angel, Honeycutt, William David, Miller, Tamara, Graves, Donna, Jacobs, Alan, Wu, Junlong, LaGanke, Christopher C.
Published in International journal of MS care (01.03.2020)
Published in International journal of MS care (01.03.2020)
Get full text
Journal Article
Comparison of Properties of Murine Monoclonal Anti-idiotypic Antibodies Generated with Idiotype-Bearing Monoclonal Antibodies to Myelin Basic Protein Peptides or Their Complementary Peptides
Zhou, Shan-Ren, Han, Qiao, Laganke, Christopher C., Whitaker, John N.
Published in Clinical immunology and immunopathology (01.03.1994)
Published in Clinical immunology and immunopathology (01.03.1994)
Get full text
Journal Article